160 related articles for article (PubMed ID: 38438647)
41. Bone marrow transplantation activity in Europe 1992: report from the European Group for Bone Marrow Transplantation (EBMT).
Gratwohl A; Hermans J
Bone Marrow Transplant; 1994 Jan; 13(1):5-10. PubMed ID: 8019452
[TBL] [Abstract][Full Text] [Related]
42. Decreased Mortality in 1-Year Survivors of Umbilical Cord Blood Transplant vs. Matched Related or Matched Unrelated Donor Transplant in Patients with Hematologic Malignancies.
Bohannon L; Tang H; Page K; Ren Y; Jung SH; Artica A; Britt A; Islam P; Siamakpour-Reihani S; Giri V; Lew M; Kelly M; Choi T; Gasparetto C; Long G; Lopez R; Rizzieri D; Sarantopoulos S; Chao N; Horwitz M; Sung A
Transplant Cell Ther; 2021 Aug; 27(8):669.e1-669.e8. PubMed ID: 33991725
[TBL] [Abstract][Full Text] [Related]
43. Chimeric Antigen Receptor T Cell Therapy versus Hematopoietic Stem Cell Transplantation: An Evolving Perspective.
Goldsmith SR; Ghobadi A; Dipersio JF; Hill B; Shadman M; Jain T
Transplant Cell Ther; 2022 Nov; 28(11):727-736. PubMed ID: 35878743
[TBL] [Abstract][Full Text] [Related]
44. Voriconazole in Hematopoietic Stem Cell Transplantation and Cellular Therapies: Real-World Usage and Therapeutic Level Attainment at a Major Transplantation Center.
Lindsay J; Krantz EM; Morris J; Sweet A; Tverdek F; Joshi A; Yeh R; Hill JA; Greenwood M; Chen SC; Kong DCM; Slavin M; Pergam SA; Liu C
Transplant Cell Ther; 2022 Aug; 28(8):511.e1-511.e10. PubMed ID: 35623614
[TBL] [Abstract][Full Text] [Related]
45. Is There Still a Role for Transplant for Patients with Mantle Cell Lymphoma (MCL) in the Era of CAR-T Cell Therapy?
Beitinjaneh A; Kaufman A; Wang Y; Jain P; Srour SA; Wang M
Curr Treat Options Oncol; 2022 Nov; 23(11):1614-1625. PubMed ID: 36227407
[TBL] [Abstract][Full Text] [Related]
46. A retrospective comparison of autologous and unrelated donor hematopoietic cell transplantation in myelodysplastic syndrome and secondary acute myeloid leukemia: a report on behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Al-Ali HK; Brand R; van Biezen A; Finke J; Boogaerts M; Fauser AA; Egeler M; Cahn JY; Arnold R; Biersack H; Niederwieser D; de Witte T
Leukemia; 2007 Sep; 21(9):1945-51. PubMed ID: 17611571
[TBL] [Abstract][Full Text] [Related]
47. American Society of Transplantation and Cellular Therapy, Center of International Blood and Marrow Transplant Research, and European Society for Blood and Marrow Transplantation Clinical Practice Recommendations for Transplantation and Cellular Therapies in Mantle Cell Lymphoma.
Munshi PN; Hamadani M; Kumar A; Dreger P; Friedberg JW; Dreyling M; Kahl B; Jerkeman M; Kharfan-Dabaja MA; Locke FL; Shadman M; Hill BT; Ahmed S; Herrera AF; Sauter CS; Bachanova V; Ghosh N; Lunning M; Kenkre VP; Aljurf M; Wang M; Maddocks KJ; Leonard JP; Kamdar M; Phillips T; Cashen AF; Inwards DJ; Sureda A; Cohen JB; Smith SM; Carlo-Stella C; Savani B; Robinson SP; Fenske TS
Transplant Cell Ther; 2021 Sep; 27(9):720-728. PubMed ID: 34452722
[TBL] [Abstract][Full Text] [Related]
48. The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy.
Ljungman P; Mikulska M; de la Camara R; Basak GW; Chabannon C; Corbacioglu S; Duarte R; Dolstra H; Lankester AC; Mohty M; Montoto S; Murray J; Peffault de Latour R; Snowden JA; Yakoub-Agha I; Verhoeven B; Kröger N; Styczynski J;
Bone Marrow Transplant; 2020 Nov; 55(11):2071-2076. PubMed ID: 32404975
[TBL] [Abstract][Full Text] [Related]
49. EBMT activity survey 2004 and changes in disease indication over the past 15 years.
Gratwohl A; Baldomero H; Frauendorfer K; Urbano-Ispizua A; ;
Bone Marrow Transplant; 2006 Jun; 37(12):1069-85. PubMed ID: 16757972
[TBL] [Abstract][Full Text] [Related]
50. Comparison of Allogeneic Transplant Outcomes Between Matched Sibling Donors and Alternative Donors in Patients Over 50 Years of Age with Acute Myeloid Leukemia: 8/8 Allele-Matched Unrelated Donors and Unrelated Cord Blood Provide Better Leukemia-Free Survival Compared with Matched Sibling Donors During Nonremission Status.
Konuma T; Yamasaki S; Ishiyama K; Mizuno S; Hayashi H; Uchida N; Shimabukuro M; Tanaka M; Kuriyama T; Onizuka M; Ishiwata K; Sawa M; Tanaka T; Ohigashi H; Fujiwara SI; Matsuoka KI; Ota S; Nishida T; Kanda Y; Fukuda T; Atsuta Y; Nakasone H; Yanada M;
Transplant Cell Ther; 2024 Feb; 30(2):215.e1-215.e18. PubMed ID: 38081415
[TBL] [Abstract][Full Text] [Related]
51. Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation.
Passweg JR; Baldomero H; Peters C; Gaspar HB; Cesaro S; Dreger P; Duarte RF; Falkenburg JH; Farge-Bancel D; Gennery A; Halter J; Kröger N; Lanza F; Marsh J; Mohty M; Sureda A; Velardi A; Madrigal A;
Bone Marrow Transplant; 2014 Jun; 49(6):744-50. PubMed ID: 24637898
[TBL] [Abstract][Full Text] [Related]
52. Outcomes of Related and Unrelated Donor Searches Among Patients with Primary Immunodeficiency Diseases Referred for Allogeneic Hematopoietic Cell Transplantation.
Acevedo MJ; Wilder JS; Adams S; Davis J; Kelly C; Hilligoss D; Carroll E; Blacklock-Schuver B; Cole K; Kang EM; Hsu AP; Kanakry CG; Dimitrova D; Kanakry JA
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1666-1673. PubMed ID: 30986499
[TBL] [Abstract][Full Text] [Related]
53. Therapy-related acute myeloid leukemia and myelodysplastic syndrome after hematopoietic cell transplantation for lymphoma.
Yamasaki S; Suzuki R; Hatano K; Fukushima K; Iida H; Morishima S; Suehiro Y; Fukuda T; Uchida N; Uchiyama H; Ikeda H; Yokota A; Tsukasaki K; Yamaguchi H; Kuroda J; Nakamae H; Adachi Y; Matsuoka KI; Nakamura Y; Atsuta Y; Suzumiya J
Bone Marrow Transplant; 2017 Jul; 52(7):969-976. PubMed ID: 28368379
[TBL] [Abstract][Full Text] [Related]
54. Results of the EBMT activity survey 2005 on haematopoietic stem cell transplantation: focus on increasing use of unrelated donors.
Gratwohl A; Baldomero H; Frauendorfer K; Urbano-Ispizua A; Niederwieser D; ;
Bone Marrow Transplant; 2007 Jan; 39(2):71-87. PubMed ID: 17213849
[TBL] [Abstract][Full Text] [Related]
55. Comparing outcomes of a second allogeneic hematopoietic cell transplant using HLA-matched unrelated versus T-cell replete haploidentical donors in relapsed acute lymphoblastic leukemia: a study of the Acute Leukemia Working Party of EBMT.
Kharfan-Dabaja MA; Labopin M; Bazarbachi A; Ciceri F; Finke J; Bruno B; Bornhäuser M; Gedde-Dahl T; Labussière-Wallet H; Niittyvuopio R; Valerius T; Angelucci E; Brecht A; Caballero D; Kuball J; Potter V; Schmid C; Tischer J; Zuckerman T; Benedetti F; Blaise D; Diez-Martin JL; Sanz J; Ruggeri A; Brissot E; Savani BN; Giebel S; Nagler A; Mohty M
Bone Marrow Transplant; 2021 Sep; 56(9):2194-2202. PubMed ID: 33931757
[TBL] [Abstract][Full Text] [Related]
56. T-cell replete haploidentical donor transplantation using post-transplant CY: an emerging standard-of-care option for patients who lack an HLA-identical sibling donor.
Bashey A; Solomon SR
Bone Marrow Transplant; 2014 Aug; 49(8):999-1008. PubMed ID: 24842530
[TBL] [Abstract][Full Text] [Related]
57. Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2011-2012: A comprehensive report on behalf of the Eastern Mediterranean Blood and Marrow Transplantation group (EMBMT).
Aljurf M; Nassar A; Hamidieh AA; Elhaddad A; Hamladji RM; Bazarbachi A; Ibrahim A; Ben Othman T; Abdel-Rahman F; Alseraihy A; Fahmy O; Hussein AA; Alabdulaaly A; Adil S; Alkindi SS; Bayoumy M; Dennison D; Bekadja MA; Redhouane AN; Rasheed W; AlSagheir A; Alsudairy R; Ladeb S; Benchekroun S; Ramzi M; Ahmed P; ElSolh H; Ahmed SO; Hussain F; Ghavamzadeh A
Hematol Oncol Stem Cell Ther; 2015 Dec; 8(4):167-75. PubMed ID: 26452331
[TBL] [Abstract][Full Text] [Related]
58. Hematopoietic cell transplantation for autoimmune disease: updates from Europe and the United States.
Sullivan KM; Muraro P; Tyndall A
Biol Blood Marrow Transplant; 2010 Jan; 16(1 Suppl):S48-56. PubMed ID: 19895895
[TBL] [Abstract][Full Text] [Related]
59. Blood and marrow transplantation activity in Europe 1995. European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Hermans J; Baldomero H
Bone Marrow Transplant; 1997 Mar; 19(5):407-19. PubMed ID: 9052905
[TBL] [Abstract][Full Text] [Related]
60. Haematopoietic cell transplantation in Switzerland, changes and results over 20 years: a report from the Swiss Blood Stem Cell Transplantation Working Group for Blood and Marrow Transplantation registry 1997-2016.
Passweg JR; Baldomero H; Ansari M; Baerlocher GM; Bargetzi M; Chalandon Y; Duchosal MA; Gerull S; Güngör T; Halter JP; Heim D; Hess U; Leibundgut K; Masouridi-Levrat S; Müller A; Nair G; Pabst T; Renner C; Schmidt A; Stussi G; Nicoloso de Faveri G; Schanz U; For The Swiss Blood Stem Cell Transplantation Group Sbst
Swiss Med Wkly; 2018; 148():w14589. PubMed ID: 29493715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
